Business Context and Reporting Period
This Form 8-K Current Report was filed by LeMaitre Vascular, Inc. on July 26, 2007, covering events that occurred on July 24, 2007. The filing primarily addresses significant changes in the Company's executive leadership structure.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The following executive leadership changes were effective July 24, 2007:
- Joseph P. Pellegrino was appointed Chief Financial Officer (CFO), succeeding David B. Roberts. Mr. Pellegrino was also designated as the Company's principal financial officer and principal accounting officer.
- David B. Roberts was promoted to President of the Company, succeeding George W. LeMaitre. Mr. Roberts will continue to serve on the Board of Directors and focus on strategic transactions.
- George W. LeMaitre remains Chairman of the Board of Directors and Chief Executive Officer (CEO).
No changes were made to the compensation arrangements for Messrs. LeMaitre, Pellegrino, or Roberts.
Guidance, Outlook, and Risks
The filing includes forward-looking statements regarding the importance of strategic acquisitions. Management notes that these statements are based on reasonable assumptions but are not guarantees. Specific risks identified include the potential inability to identify or complete additional strategic acquisitions on satisfactory terms. The Company disclaims any obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the professional background and prior experience of the new CFO, Joseph P. Pellegrino, particularly his tenure at Zoots, Inc. and Lehman Brothers.
- Confirm the strategic focus of the new President, David B. Roberts, regarding future acquisitions.
- Review the attached press release (Exhibit 99.1) for any additional details on the leadership transition not included in the 8-K text.
- Check the most recent Form 10-K for detailed risk factors related to strategic acquisitions mentioned in this filing.